Skip to main content

Table 5 Central venous pressure (mmHg)

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 

Terlipressin group (n = 50)

Placebo group (n = 50)

P value

Baseline

4.2 ± 3.9

4.3 ± 3.7

0.8956

0 min

7.1 ± 6.8

8.6 ± 7.9

0.3114

10 min

6.8 ± 6.7

8.9 ± 8.1

0.1609

20 min

6.9 ± 6.6

8.4 ± 7.9

0.3054

30 min

7.2 ± 6.9

8.7 ± 7.8

0.3109

40 min

6.9 ± 6.7

8.3 ± 7.7

0.3345

50 min

7.1 ± 6.6

8.4 ± 7.4

0.3562

60 min

6.9 ± 6.9

8.3 ± 7.6

0.3372

  1. Baseline reading before skin incision
  2. Minutes after weaning from cardiopulmonary bypass
  3. Mean ± SD
  4. *P value is significant when P < 0.05